Skip to search formSkip to main contentSkip to account menu

Stage IV Pancreatic Cancer

Known as: Stage IV Pancreatic Cancer AJCC v6, Stage IV Carcinoma of the Pancreas, Stage IV Pancreatic Cancer AJCC v7 
Cancer may be of any size and has spread to distant organs, such as the liver, lung, and peritoneal cavity (the body cavity that contains most of the… 
National Institutes of Health

Related topics

Related topics

11 relations
Epithelial CellsEpitheliumExocrine pancreasGastrointestinal system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Longitudinal Health-Related Quality of Life Assessment Implications for Prognosis in Stage IV Pancreatic Cancer
Objectives We investigated whether changes in quality of life (QoL) during treatment could predict survival in stage IV… 
2012
2012
Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome.
CD4(+)CD25(+)FoxP3(+) regulatory T cells (Tregs) are understood to maintain peripheral tolerance to self-antigens and inhibit… 
2009
2009
Metastatic Pancreatic Carcinoma Presenting as Colon Carcinoma
Determining the origin of poorly differentiated adenocarcinomas remains a challenge for the pathologist. This manuscript reports… 
2005
2005
A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer
4099 Background: Patients with advanced pancreatic cancer who fail first-line gemcitabine-based therapy have no standard… 
2004
2004
Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group.
2004
2004
Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma
Background: In advanced pancreatic carcinoma, no effective chemotherapy has been found yet due to the lack of appropriate… 
Highly Cited
2003
Highly Cited
2003
The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
Pancreatic carcinoma still has the highest mortality rate in comparison to any other malignancy. Major reasons are late detection… 
Highly Cited
2003
Highly Cited
2003
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.
PURPOSE Preclinical studies indicate positive interactions between capecitabine, an oral fluorouracil precursor, and gemcitabine… 
2000
2000
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer…
BACKGROUND Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m2/min may be more effective than the… 
1998
1998
Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids.
Because of the poor response of pancreatic cancer to conventional therapy, the authors performed a phase II pilot study to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)